首页> 外文期刊>British Journal of Clinical Pharmacology >Drug combinations and impaired renal function -- the 'triple whammy'.
【24h】

Drug combinations and impaired renal function -- the 'triple whammy'.

机译:药物组合和肾功能受损-“三重打击”。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Recent studies have identified the 'triple whammy' in which combinations of diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), ACE inhibitors (ACEI) and/or angiotensin receptor antagonists (ARA) may impair renal function. METHODS: We performed a cross-sectional study of patients admitted to a general medical ward of a teaching hospital. Age, sex, disease status and prior consumption of the 'target' drugs, diuretics, NSAIDs (including aspirin), ACEI and ARA were correlated with creatinine and creatinine clearance on admission. RESULTS: Three hundred and one patients (48% male) were included, 135 were on no prior target drugs, 87 on one, 60 on two and 19 on three such drugs. There was a significant (P < 0.01) correlation between both creatinine and creatinine clearance with male sex, age and number of target drugs. Multivariate analysis confirmed these associations but did not support associations between renal function and heart failure or total number of diagnoses. Increasing doses of diuretics, possibly because in many cases this included two drugs, but not the other drugs, were significantly (P < 0.001) associated with impaired renal function. For the other three drug groups patients on doses of any drug at lower than the defined daily dose (DDD) did not have significantly different creatinine or creatinine clearance from those on doses at or above the DDD. CONCLUSION: Taking two or more of the identified drugs was associated with significant renal impairment but did not correlate with heart failure or other diseases for which the drugs might have been prescribed. Care is necessary to balance the demonstrated advantages of these medications against the risk of inducing renal failure.
机译:背景:最近的研究已经确定了利尿剂,非甾体抗炎药(NSAIDs),ACE抑制剂(ACEI)和/或血管紧张素受体拮抗剂(ARA)组合使用可能会损害肾功能的“三重打击”。方法:我们对入院教学医院普通病房的患者进行了横断面研究。年龄,性别,疾病状况和“目标”药物,利尿剂,NSAID(包括阿司匹林),ACEI和ARA的先前食用与入院时的肌酐和肌酐清除率相关。结果:包括301例患者(男性48%),其中135例未使用既往目标药物,其中87例未使用目标药物,二人60例,三种药物19例。肌酐和肌酐清除率与男性,年龄和目标药物数量之间存在显着(P <0.01)相关性。多变量分析证实了这些关联,但不支持肾功能与心力衰竭或诊断总数之间的关联。利尿剂剂量的增加,可能是因为在许多情况下,这包括两种药物,但不包括其他药物,与肾脏功能受损显着相关(P <0.001)。对于其他三个药物组,任何剂量低于规定日剂量(DDD)的患者的肌酐或肌酐清除率均与DDD或更高剂量组的肌酐或肌酐清除率无显着差异。结论:服用两种或两种以上已确定的药物与严重肾功能损害相关,但与心力衰竭或可能已开具该药物的其他疾病无关。必须谨慎地权衡这些药物已证明的优势与诱发肾功能衰竭的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号